Glucagon receptor antagonist
This page covers all Glucagon receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Glucagon receptor, Glucagon receptor (GCGR).
Targets
Glucagon receptor · Glucagon receptor (GCGR)
Phase 3 pipeline (4)
- GZR4 Injection · Gan and Lee Pharmaceuticals, USA · Diabetes
GZR4 Injection is a glucagon receptor antagonist. - NNC6019-0001 · Novo Nordisk A/S · Diabetes
NNC6019-0001 is a glucagon receptor antagonist that blocks glucagon signaling to reduce hepatic glucose production and improve glycemic control. - MK-0524B · Merck Sharp & Dohme LLC · Diabetes
MK-0524B is a glucagon receptor antagonist. - MK-1293 · Merck Sharp & Dohme LLC · Diabetes
MK-1293 is a glucagon receptor antagonist.
Phase 2 pipeline (7)
- ATL-104 · Alizyme · Diabetes
ATL-104 is a glucagon receptor antagonist. - JNJ16269110 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Diabetes
JNJ16269110 is a selective and potent antagonist of the human glucagon receptor. - GW642444 6.25 · GlaxoSmithKline · Diabetes
GW642444 is a glucagon receptor antagonist. - AGN-195263 0.03% · Allergan · Diabetes
AGN-195263 is a glucagon receptor antagonist. - ABT-288 High Dose · AbbVie (prior sponsor, Abbott) · Diabetes
ABT-288 High Dose is a glucagon receptor antagonist. - ARA 290 · Claes-Göran Östenson · Diabetes
ARA 290 is a peptide that acts as a glucagon receptor antagonist. - ATL-962 · Alizyme · Diabetes
ATL-962 is a glucagon receptor antagonist.